ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2621

Association Between Outcome Renal, Clinical Variables and Findings of Renal Biopsy in Patients with ANCA Vasculitis

Linda Vergel Orduz1, Alejandro Brigante 2, Diego Marino 3, Natalia Perrotta 3, Romina Hassan 4, Gisele Verna 5, Adriana Hamaui 6, Eduardo Kerzberg 7 and Diana Dubinsky 6, 1Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, 2Sanatorio Güemes, Servicio de Medicina Interna – Reumatología, Francisco Acuña de Figueroa 1240, C1180AAD, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 3Hospital de Clínicas José de San Martín, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 4Hospital Ramos Mejía, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 5Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 6Sanatorio Güemes, Buenos Aires, Argentina, 7Hospital Ramos Mejia, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ANCA, biopsies and renal, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In associated ANCA vasculitis (AAV), rapidly progressive glomerulonephritis (GN) is one of the most serious complications. In 40% of cases they progress to chronic kidney disease (CKD), others to hemodialysis (HD) or death. According to the classification of the European AAV group (EUVAS), the histopathological findings of the biopsy can predict the outcome renal with better results in the focal class, followed by the mixed and sclerotic class. Our objective is to evaluate the association between outcome renal and histopathological findings of patients with AAV

Methods: Cohort study, retrospective patients with AAV (ACR 1990 / Chapell Hill 2012) and rapidly progressive GN of three centers of high complexity in the Autonomous City of Buenos Aires between January 2012 – December 2018. Demographic, clinical, analytical variables were recorded and follow-up for one year, at diagnosis. The immunoserology patterns (ANCA and PR3 / MPO), Five Factor Score (FFS), BVASv3 (0-63) and VDI (0-64) per year are evaluated. Renal biopsies (optical microscopy and immunofluorescence) were reviewed. The glomerular lesions were classified according to EUVAS and its association with CKD, HD and death was evaluated

Results: 33 patients were included, 57.6% males. Mean age 51 (SD +/- 16 IC 95% 45-58). GPA 65%, and MPA 33%. ANCAc n: 20, PR3 52%. ANCAp n: 13, MPO 30%. Histopathology: Glomerular lesions: Focal 18%, Crescentic 27% Sclerotic 12% and Mixed 43%. Grade 1: 24%, grade 2: 27% and grade 3: 49%. Fibrinoid necrosis in 61%. Global Interstitial Commitment (tubilitis, tubular atrophy, fibrosis and inflammatory infiltrate) 97%; grade 0: 12%, grade 1: 58%, grade 2: 30%. cell infiltrate in 85% monomorphonuclear 73%, polymorphonuclear 6%. Vascular damage (subintimal sclerosis) 79%: mild 46%, moderate in 36% and severe 11%. The patients presented severe clinical compromise with a median BVASv3 15 (RIC 7-48). FFS: I: 24%; II: 42%; III: 18%; IV: 6%. PCR 23 (RIC 1-321) and VDI at year 3 (RIC 2-5), the baseline clinical variables and at one year are summarized in Table 1.

HD requirement at the start of 36%, achieving independence of HD (HDI) per year by 30%, the variables associated with HDI were Crb and eGFR  p = 0.014 and p = 0.012 respectively and focal class with p = 0.032. The CKD was 33%, with the mixed class being the most associated p = 0.017. Relapse in 30% associated with the type of glomerular lesion with p = 0.006. Death 4 (activity and infection). The association between tubulointerstitial involvement and CKD and HDI was not significant.

Conclusion: Crb and the glomerular filtration rate were the best predictors of CKD and HDI. The mixed class was associated with CKD. We found an association between the focal class and the HDI. Relapses are associated with the type of glomerular pattern. The percentage of progression to CKD was low and high rate of HDI. There was no association between tubulointerstitial involvement and progression to CKD.


Clinical Variable Table


Disclosure: L. Vergel Orduz, None; A. Brigante, None; D. Marino, None; N. Perrotta, None; R. Hassan, None; G. Verna, None; A. Hamaui, None; E. Kerzberg, None; D. Dubinsky, None.

To cite this abstract in AMA style:

Vergel Orduz L, Brigante A, Marino D, Perrotta N, Hassan R, Verna G, Hamaui A, Kerzberg E, Dubinsky D. Association Between Outcome Renal, Clinical Variables and Findings of Renal Biopsy in Patients with ANCA Vasculitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/association-between-outcome-renal-clinical-variables-and-findings-of-renal-biopsy-in-patients-with-anca-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-outcome-renal-clinical-variables-and-findings-of-renal-biopsy-in-patients-with-anca-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology